Bridging Pharma and Patients in Neuroendocrine Cancer Care
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Bridging Pharma and Patients in Neuroendocrine Cancer Care
-
Narrated by:
-
By:
🎙️ In this episode of the Not Just NE Cancer podcast, Neuroendocrine Cancer UK CEO and Co-Founder, Cathy Bouvier Ellis sits down with Tanya Hills, Global Patient Engagement Lead at Boehringer Ingelheim.
Together, they explore:
- Common misconceptions about the pharmaceutical industry
- How patient organisations and the industry can work collaboratively
- How effective these collaborations can be
Tanya also highlights a current clinical trial led by Boehringer Ingelheim for Extrapulmonary Neuroendocrine Carcinoma (EP-NEC). You can find more information about this trial here:
🔗 Boehringer Ingelheim – EP-NEC Clinical Trial
To learn more about ongoing neuroendocrine cancer research, visit our website:
🔗 Neuroendocrine Cancer UK – Research
Support the show
adbl_web_anon_alc_button_suppression_t1
No reviews yet